PENSACOLA, Fla.--(BUSINESS WIRE)--Reckitt Benckiser (LON: RKT) subsidiary, Mead Johnson is facing the first bellwether today as part of a multidistrict litigation (MDL) in the US District Court for the Northern District of Illinois over its infant formula Enfamil being linked to necrotizing enterocolitis (NEC) in a premature infant. Inman v. Mead Johnson & Company, LLC, et al. is the first case...
The Lysol, Mucinex and Durex-condom maker issued a new share buyback program after reporting 4.7% like-for-like net revenue, bolstered by growth in emerging markets.
Reckitt Benckiser Group PLC (LSE:RKT) has launched a new £500 million share buyback after second-quarter sales accelerated across all regions and product categories. The maker of consumer products brands ranging from Dettol to Durex said like-for-like net revenue rose 4.7% in the second quarter, lifting first-half growth to 2.6%.
Dettol maker Reckitt beat second-quarter sales growth estimates and reaffirmed its annual forecast on Wednesday, as strong demand in China, India and other emerging markets helped offset weakness in Europe and disruption linked to the Iran war.
The deal with Russia's Arnest Management—which manufactures cosmetics and household goods—is expected to complete during the second half of 2026.
Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB) has agreed to sell its Russian household hygiene business more than four years after first announcing exit plans in the wake of the Ukraine invasion, though it will still retain a presence in the country via its health business. The Dettol and Lysol maker will divest the business for an undisclosed sum to Russia's Arnest Management, whic...
Britain's Reckitt Benckiser Group said on Friday that it has agreed to divest its Russian hygiene business to Arnest Management LLC for an undisclosed sum.